Jeffrey Bockman

Jeffrey Bockman

Company: Lumanity

Job title: Executive Vice President of Commercial BioConsulting & Head of Oncology


Is There a Single “Best” Platform or Will it be “Fit to Purpose”? 5:45 pm

• Analysing the advantages, disadvantages and comparisons of the DNA, Peptide, RNA, and Virus-based and other novel vaccine platforms • Harmonisation of clinical outcomes and immune correlates • Considering if we can we get better at predictive animal models? • Questioning what other signals we need to provide to the immune system, either built into…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.